Cargando…
Synthesis of RP 48497, an Impurity of Eszopiclone
RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-on...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245065/ https://www.ncbi.nlm.nih.gov/pubmed/18794786 http://dx.doi.org/10.3390/molecules13081817 |
_version_ | 1783372168881504256 |
---|---|
author | Sha, Yu Zhang, Lei Du, Gui-Jie Ren, Jian Cheng, Mao-Sheng |
author_facet | Sha, Yu Zhang, Lei Du, Gui-Jie Ren, Jian Cheng, Mao-Sheng |
author_sort | Sha, Yu |
collection | PubMed |
description | RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its (1)H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone. |
format | Online Article Text |
id | pubmed-6245065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62450652018-11-26 Synthesis of RP 48497, an Impurity of Eszopiclone Sha, Yu Zhang, Lei Du, Gui-Jie Ren, Jian Cheng, Mao-Sheng Molecules Communication RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its (1)H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone. MDPI 2008-08-22 /pmc/articles/PMC6245065/ /pubmed/18794786 http://dx.doi.org/10.3390/molecules13081817 Text en © 2008 by the authors. Licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Communication Sha, Yu Zhang, Lei Du, Gui-Jie Ren, Jian Cheng, Mao-Sheng Synthesis of RP 48497, an Impurity of Eszopiclone |
title | Synthesis of RP 48497, an Impurity of Eszopiclone |
title_full | Synthesis of RP 48497, an Impurity of Eszopiclone |
title_fullStr | Synthesis of RP 48497, an Impurity of Eszopiclone |
title_full_unstemmed | Synthesis of RP 48497, an Impurity of Eszopiclone |
title_short | Synthesis of RP 48497, an Impurity of Eszopiclone |
title_sort | synthesis of rp 48497, an impurity of eszopiclone |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245065/ https://www.ncbi.nlm.nih.gov/pubmed/18794786 http://dx.doi.org/10.3390/molecules13081817 |
work_keys_str_mv | AT shayu synthesisofrp48497animpurityofeszopiclone AT zhanglei synthesisofrp48497animpurityofeszopiclone AT duguijie synthesisofrp48497animpurityofeszopiclone AT renjian synthesisofrp48497animpurityofeszopiclone AT chengmaosheng synthesisofrp48497animpurityofeszopiclone |